Pruitt Sheri D, Khan Rabia, Chaiyakunapruk Nathorn, Phrommintikul Arintaya, Aguilera Miguel Angel Díaz, Tan Ngiap Chuan, Afzal Shoaib, da Silva van der Laan Andressa, Weinman John
Former Director of Behavioral Science Integration, Independent Behavioral Science Consultant, Kaiser Permanente, Ada, OK, USA.
School of Population Health, University of New South Wales, New South Wales, Australia.
BMC Proc. 2025 May 22;19(Suppl 10):13. doi: 10.1186/s12919-025-00326-4.
Medication non-adherence is a global challenge with profound implications for patient health outcomes, healthcare systems, and society at large. This widespread issue leads to hundreds of thousands of preventable deaths and hospitalizations annually, and billions of dollars in avoidable healthcare costs. No country is immune to this challenge. The a:care Congress 2024, titled "Adherence is a Behavior: Do We Have the Right One?", addressed this critical issue to understand its societal and economic burden and explore the complex human behaviors driving it. The Congress examined the global impact of non-adherence and local realities, providing a health economic perspective on its consequences. Behavioral factors influencing adherence were analyzed, emphasizing the importance of understanding individual patient motivations. The role of technology and artificial intelligence in the physician-patient relationship was discussed, highlighting opportunities and challenges of integrating these tools. The patient's voice was brought to the forefront, underscoring the importance of communication and trust in the care relationship. A final multidisciplinary session explored the role of each stakeholder in improving adherence. This article provides an overview of the different sessions from the congress, focusing on the challenges associated with medication non-adherence and potential solutions. It emphasizes the need for a multidimensional approach involving all healthcare system stakeholders and the importance of prioritizing the development of new strategies to improve overall health outcomes and healthcare system efficiency.
药物治疗依从性是一项全球性挑战，对患者健康结局、医疗保健系统乃至整个社会都有着深远影响。这一普遍问题每年导致数十万例可预防的死亡和住院病例，并造成数十亿美元本可避免的医疗费用。没有哪个国家能免受这一挑战的影响。2024年的a:care大会主题为“依从性是一种行为：我们选择的行为正确吗？”，探讨了这一关键问题，以了解其社会和经济负担，并探究导致该问题的复杂人类行为。大会审视了不依从的全球影响和当地实际情况，从卫生经济学角度分析了其后果。分析了影响依从性的行为因素，强调了理解个体患者动机的重要性。讨论了技术和人工智能在医患关系中的作用，突出了整合这些工具的机遇和挑战。患者的声音被置于首位，强调了医患关系中沟通和信任的重要性。最后一场多学科会议探讨了各利益相关方在提高依从性方面的作用。本文概述了大会的不同场次内容，重点关注与药物治疗不依从相关的挑战及潜在解决方案。它强调了采取涉及所有医疗保健系统利益相关方的多维方法的必要性，以及优先制定新策略以改善整体健康结局和提高医疗保健系统效率的重要性。
